U.S. Metals and Mining Stock News

Anbio Biotechnology, NasdaqGM:NNNN, is expanding beyond COVID-19 diagnostics into a broader test portfolio. The company is rolling out new rapid immunoassay and PCR platforms across human health, veterinary, and multi-disease applications. This move reflects a business model shift toward more diversified diagnostic revenues and reduced reliance on legacy COVID-19 products. For you as an investor, this repositioning matters because Anbio Biotechnology is moving from a single product focus...

EQT (NYSE:EQT) agreed to purchase an additional 1 million metric tons of LNG per year from Commonwealth LNG, bringing its total contracted volume to 2 million tons annually. Glencore now has long-term commitments for 3 million tons of LNG per year from Commonwealth LNG. With these contracts, Commonwealth LNG reports that 8 of its planned 9.5 million tons of annual capacity is now under long-term agreements. EQT is a major U.S. natural gas producer, and this latest LNG deal increases its...

Wondering whether Perrigo's current share price makes sense or if the market has mispriced it? This article walks through the key valuation clues that can help you frame that question. The stock has seen a 0.1% move over the last 7 days and a 16.8% return over the past month, set against a much tougher picture with a 21.8% decline year to date and a 52.9% fall over the last year, as well as 65.7% and 68.3% declines over 3 and 5 years respectively. Recent attention on Perrigo has focused less...

ASP Isotopes (ASPI) has just put out its FY 2025 numbers, with Q4 revenue of about US$16.7 million and a Q4 basic EPS loss of US$0.76. Trailing twelve month revenue sits at roughly US$23.8 million against a TTM basic EPS loss of US$2.11. The company has seen quarterly revenue move from around US$1.2 million in Q4 FY 2024 to US$16.7 million in Q4 FY 2025, while trailing twelve month revenue shifted from about US$4.1 million to US$23.8 million over the same window. Investors will now be...

Unity Software (NYSE:U) is pivoting its ads business toward AI, positioning the Vector ad platform as its primary growth driver. The company is sunsetting the legacy ironSource Ads Network and is exploring a sale of its Supersonic publishing unit. Management expects Vector to reach a billion dollar annual run rate, with recent trends supporting upgrades to company guidance. Unity Software enters this shift with a share price of $21.62 and a mixed return profile, including a 51.1% decline...

State Street (NYSE:STT) has filed to launch a Nasdaq 100 Index ETF, entering a segment where Invesco has been a long-standing player. The firm is extending its relationship with Thornburg Investment Management to service new ETF share classes across Thornburg funds. Shareholders have introduced a proposal seeking a policy for an independent board chair at State Street. For investors watching the ETF space, these moves put State Street, a major global custody bank and asset manager, closer...

Adlai Nortye (NasdaqGM:ANL) has posted its FY 2025 first half results with total revenue of effectively US$0, a basic EPS loss of US$0.57 and net income loss of US$18.34 million, keeping the story firmly about cash burn and margins rather than top line scale. The company has seen recent periods marked by similarly low reported revenue, with basic EPS losses of US$0.64 and US$1.06 and net income losses of US$24.26 million and US$27.61 million across the two halves of FY 2024. As a result,...

In April 2026, Immunovant reported that two Phase 3 GO studies of its FcRn inhibitor batoclimab in adults with active, moderate-to-severe thyroid eye disease did not meet the pre-specified primary endpoint of ≥2mm proptosis response at Week 24, though safety findings remained consistent and no new signals emerged. The data suggested stronger proptosis improvements during the initial high-dose period and thyroid hormone normalization in hyperthyroid patients similar to prior Graves’ disease...

Core & Main’s recent Q4 earnings report showed a 6.9% year-on-year revenue decline and slight misses on both quarterly revenue and full-year EBITDA guidance compared with analyst expectations. Despite these softer figures, investor reaction suggests the market may have been braced for weaker results or took confidence from management’s commentary and forward-looking remarks. We’ll now explore how the softer Q4 revenue and guidance miss may reshape Core & Main’s broader investment narrative...

Medline (NasdaqGS:MDLN) has received an FDA warning letter citing manufacturing deficiencies in its angiographic syringe production. The letter, the first major regulatory challenge since Medline went public, focuses on quality and compliance issues with potential patient safety implications. The FDA action requires Medline to address identified problems and document corrective steps before the matter can be closed. For investors following Medline at a share price of $45.6, this FDA warning...

Wondering whether Nutanix at around US$34.41 is a bargain or a value trap? This article breaks down what that price could imply for you. The stock has seen sharp swings recently, with a 16.3% decline over the last 7 days, a 10.0% decline over 30 days, a 32.0% decline year to date and a 42.0% decline over the last year, even though 3 year and 5 year returns sit at 34.9% and 25.9% respectively. Recent coverage has focused on Nutanix as a key player in cloud infrastructure software and as a...

In recent months, ClearBridge Investments added The Ensign Group, Inc. to its Small Cap Growth Strategy after the company delivered strong fourth-quarter 2025 earnings with margins and adjusted EPS ahead of forecasts despite slightly softer revenue. This combination of new institutional interest and consistent growth through acquisitions in a still-fragmented skilled nursing market highlights how Ensign’s consolidation model remains central to its business story, even as return on invested...

In early April 2026, Fortune Brands Innovations, Inc. disclosed disappointing Q4 results with full-year EPS guidance below analyst expectations, while also filing proxy materials urging shareholders to vote against a proposal to require annual election of all directors at the upcoming May 5, 2026 annual meeting. An interesting twist is that, even as the company encourages investors to reject a shareholder declassification proposal, it has already obtained approval to amend its certificate...

Jackson Financial (JXN) is in focus after the company reshaped its leadership by naming Christopher A. Raub as President and CEO of asset manager PPM America and adjusting roles at Jackson National Life Insurance Company. See our latest analysis for Jackson Financial. Recent leadership changes come as Jackson Financial’s share price has eased in the short term, with a 30 day share price return showing a 5.21% decline and a 90 day share price return showing a 13.41% decline. At the same time,...

Why Quest Diagnostics Stock Is Getting Attention Without a single headline event driving sentiment, Quest Diagnostics (DGX) is drawing interest as investors weigh its recent share performance alongside current profitability, revenue mix, and overall value score. The stock’s moves over the past week and month, combined with its longer term total returns and current valuation metrics, are prompting closer attention from investors looking at large US healthcare service providers. See our latest...

Acuity Inc. recently reported past second-quarter 2026 results, with sales rising to US$1,055.7 million and net income to US$96.8 million, while six-month sales reached US$2,199.4 million and net income US$217.3 million. Earnings per share from continuing operations improved on both a basic and diluted basis for the quarter and first half, underlining stronger profitability alongside the company’s push into AI-assisted Intelligent Spaces. We’ll now examine how this stronger profitability,...

CNO Financial Group recently reported quarterly revenue of US$1.01 billion, rising 2.4% year on year and exceeding analysts’ expectations for both sales and earnings. Around the same time, AM Best reaffirmed the insurer’s A (Excellent) financial strength rating, underscoring its very strong balance sheet and stable premium growth. Next, we’ll consider how AM Best’s reaffirmed A rating and the earnings beat may influence CNO Financial Group’s investment narrative. This technology could...

Earlier this week, Abercrombie & Fitch announced a renewed global collaboration with Sperry, launching a limited-edition apparel and footwear collection inspired by their shared 1930s heritage and coastal Americana style, now available online and in select stores. The tie-up not only revives a historic brand relationship but also reinforces Abercrombie’s push into curated collaborations that can attract new customers at the start of the key spring–summer shopping season. We’ll now explore...

What Byline Bancorp’s new shelf registration could mean for investors Byline Bancorp (BY) has filed an omnibus shelf registration covering common and preferred stock, depositary shares, debt securities, warrants, purchase contracts, and units. This gives the bank board-authorized flexibility to raise capital over time. See our latest analysis for Byline Bancorp. Byline Bancorp’s latest share price of US$33.15 sits against a 30 day share price return of 8.3% and year to date share price return...

In recent days, Sunbelt Rentals Holdings reported total revenue growth, a 2.6% increase in rental revenue, record free cash flow, US$1.90 billion of year-to-date investment in rental fleet, greenfield expansions and ten bolt-on acquisitions, and launched a new US$1.50 billion share buyback program under its Sunbelt 4.0 plan. This combination of increased rental activity, heavy reinvestment and sizable share repurchases highlights management’s confidence in the company’s cash generation and...

We feel now is a pretty good time to analyse QuickLogic Corporation's ( NASDAQ:QUIK ) business as it appears the...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Some Whitehawk Therapeutics, Inc. ( NASDAQ:WHWK ) shareholders may be a little concerned to see that the President...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...